CIK: 0001306923 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 15, 2023
Total Value ($000): $1,207,102 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,831,035 | $178,050 | 14.8% | $83.16 | +24.7% | COM | 09061G101 |
| — | REVANCE THERAPEUTICS INC | 5,270,209 | $169,753 | 14.1% | $21.40 | — | COM | 761330109 |
| UTHR | UNITED THERAPEUTICS CORP | 627,514 | $140,538 | 11.6% | $89.23 | +176.3% | COM | 91307C102 |
| FOLD | AMICUS THERAPEUTICS INC | 10,524,022 | $116,711 | 9.7% | $9.63 | +28.1% | COM | 03152W109 |
| BIIB | BIOGEN INC | 381,282 | $106,008 | 8.8% | $264.98 | +4.4% | COM | 09062X103 |
| INSM | INSMED INC | 5,889,491 | $100,416 | 8.3% | $17.79 | +9.2% | COM | 457669307 |
| STAA | STAAR SURGICAL CO | 1,347,322 | $86,161 | 7.1% | $23.48 | +177.9% | COM | 852312305 |
| PRTA | PROTHENA CORP PLC | 1,663,777 | $80,643 | 6.7% | $21.46 | +146.2% | COM | G72800108 |
| ACAD | ACADIA PHARMACEUTICALS INC | 2,405,793 | $45,277 | 3.8% | $28.41 | -33.0% | COM | 004225108 |
| — | SAGE THERAPEUTICS INC | 859,517 | $36,065 | 3.0% | $46.62 | — | COM | 78667J108 |
| EHTH | EHEALTH INC | 2,689,379 | $25,173 | 2.1% | $38.69 | -79.7% | COM | 28238P109 |
| ALGN | ALIGN TECHNOLOGY INC | 74,605 | $24,929 | 2.1% | $149.18 | +97.8% | COM | 016255101 |
| — | KARYOPHARM THERAPEUTICS INC | 5,675,876 | $22,079 | 1.8% | $16.36 | — | COM | 48576U106 |
| ALKS | ALKERMES PLC | 603,400 | $17,010 | 1.4% | $22.36 | +21.8% | COM | G01767105 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 612,600 | $12,938 | 1.1% | $16.84 | +47.7% | COM | 87164F105 |
| — | PROVENTION BIO INC | 390,800 | $9,418 | 0.8% | $4.50 | — | COM | 74374N102 |
| ANAB | ANAPTYSBIO INC | 431,224 | $9,383 | 0.8% | $19.06 | +27.5% | COM | 032724106 |
| GOSS | GOSSAMER BIO INC | 3,465,152 | $4,366 | 0.4% | $2.02 | -5.4% | COM | 38341P102 |
| CYTK | CYTOKINETICS INC | 111,717 | $3,931 | 0.3% | $6.71 | +507.7% | COM | 23282W605 |
| TVTX | TRAVERE THERAPEUTICS INC | 166,069 | $3,735 | 0.3% | $23.56 | -9.8% | COM | 89422G107 |
| VNDA | VANDA PHARMACEUTICALS INC | 482,697 | $3,278 | 0.3% | $11.21 | -37.3% | COM | 921659108 |
| — | KEZAR LIFE SCIENCES INC | 656,200 | $2,054 | 0.2% | $5.16 | — | COM | 49372L100 |
| NVCR | NOVOCURE LTD | 32,790 | $1,972 | 0.2% | $79.91 | 0.0% | COM | G6674U108 |
| — | GRITSTONE ONCOLOGY INC | 666,127 | $1,852 | 0.2% | $9.42 | — | COM | 39868T105 |
| ALDX | ALDEYRA THERAPEUTICS INC | 160,800 | $1,597 | 0.1% | $7.10 | -0.4% | COM | 01438T106 |
| MIRM | MIRUM PHARMACEUTICALS INC | 64,700 | $1,554 | 0.1% | $15.56 | +46.5% | COM | 604749101 |
| RLMD | RELMADA THERAPEUTICS INC | 542,100 | $1,225 | 0.1% | $3.45 | 0.0% | COM | 75955J402 |
| TCMD | TACTILE SYSTEMS TECHNOLOGY I | 27,100 | $445 | 0.0% | $39.74 | -65.0% | COM | 87357P100 |
| — | PEAK BIO INC | 497,528 | $314 | 0.0% | $4.06 | — | COM | 70470P108 |
| URGN | UROGEN PHARMA LTD | 24,500 | $226 | 0.0% | $27.01 | -65.9% | COM | M96088105 |